Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page
- Check6 days agoChange DetectedThe study history UI now shows a standardized 'Find contact information' label and the latest revision tag (v3.7.0). This replaces the previous capitalization ('Find Contact Information') and the older tag (v3.6.6).SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAn updated revision entry 'v3.6.6' is now listed in the record history, replacing the previous 'v3.6.5'. This reflects a metadata update to the study record rather than a substantive study content change.SummaryDifference0.1%

- Check48 days agoChange DetectedStudy record history now lists revision v3.6.5, replacing the prior v3.6.4 and indicating an updated version label in the revision history.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry 'Revision: v3.6.4' was added to the study record history, and the previous 'Revision: v3.6.3' entry was removed. This reflects a platform release update to the page's revision history.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, signaling an update to the page version and superseding the previous revision (v3.6.2).SummaryDifference0.1%

- Check91 days agoChange DetectedThe history now shows a new revision entry (v3.6.2) and removes the previous revision (v3.6.0), indicating an update to the page's release version. This change reflects an administrative update to the page rendering rather than content changes.SummaryDifference0.1%

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.